Jamie Lowe

Title: Jamie Lowe: Innovator in Immunopharmacodynamics

Introduction

Jamie Lowe is an accomplished inventor based in Woodbury, MN (US). She has made significant contributions to the field of immunotherapy, particularly through her innovative research and patent in the area of beta glucan immunopharmacodynamics. Her work aims to optimize treatment strategies for patients undergoing immunotherapy.

Latest Patents

Jamie Lowe holds a patent titled "Beta glucan immunopharmacodynamics." This patent provides dosing strategies for soluble β-glucan immunotherapy to enhance acute immunopharmacodynamic responses. It also outlines a method for analyzing biological samples from subjects to identify appropriate dosing strategies based on biomarker levels. The method includes obtaining a sample, analyzing it for anti-β-glucan antibody levels, and classifying subjects into subgroups to determine the best dosing approach.

Career Highlights

Jamie is currently associated with Hibercell, Inc., where she continues to advance her research in immunotherapy. Her innovative approach has the potential to significantly impact treatment outcomes for patients receiving immunotherapy.

Collaborations

Jamie collaborates with notable colleagues, including Nandita Bose and Ben Harrison, who contribute to her research efforts and the development of new therapeutic strategies.

Conclusion

Jamie Lowe is a pioneering inventor whose work in beta glucan immunopharmacodynamics is shaping the future of immunotherapy. Her contributions are vital for optimizing treatment strategies and improving patient outcomes.